UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents

International review of cell and molecular biology, 2017, Vol.330, p.115-156

2017

Volltextzugriff (PDF)

Calreticulin and cancer

Cell research, 2021-01, Vol.31 (1), p.5-16

2021

Volltextzugriff (PDF)

Detection of immunogenic cell death and its relevance for cancer therapy

Cell death & disease, 2020-11, Vol.11 (11), p.1013-1013, Article 1013

2020

Volltextzugriff (PDF)

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

Oncoimmunology, 2018-12, Vol.7 (12), p.e1526250-e1526250

2018

Volltextzugriff (PDF)

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (7), p.1746-1756

2016

Volltextzugriff (PDF)

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells

Oncoimmunology, 2021-01, Vol.10 (1), p.1962592-1962592

2021

Volltextzugriff (PDF)

181P Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

Immuno-oncology technology, 2023-12, Vol.20, p.100640, Article 100640

2023

Volltextzugriff (PDF)

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.312-12, Article 312

2019

Volltextzugriff (PDF)

Effects of 5-azacytidine and trichostatin A on dendritic cell maturation

Journal of biological regulators and homeostatic agents, 2011-10, Vol.25 (4), p.517-529

2011

Volltextzugriff (PDF)

Trial watch: Immune checkpoint blockers for cancer therapy

Oncoimmunology, 2017-01, Vol.6 (11), p.e1373237-e1373237

2017

Volltextzugriff (PDF)

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

Oncoimmunology, 2018-01, Vol.7 (6), p.e1433982-e1433982

2018

Volltextzugriff (PDF)

Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death

Methods in enzymology, 2020, Vol.632, p.15-25

2020

Volltextzugriff (PDF)

P03.24 Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A32-A32

2020

Volltextzugriff (PDF)

FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer

Clinical immunology (Orlando, Fla.), 2009-04, Vol.131 (1), p.1-10

2009

Volltextzugriff (PDF)

Anthracyclins Induce Immunogenic Cell Death in Human Acute Lymphoblastic Leukemia Cell Lines

Clinical immunology (Orlando, Fla.), 2009-01, Vol.131, p.S60-S61

2009

Volltextzugriff (PDF)

872 Long-term immunotherapy by dendritic-cells based vaccine in patients with PSA-recurrent prostate cancer

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e872-e872

2014

Volltextzugriff (PDF)

The Concept of Immunogenic Cell Death in Antitumor Immunity

Klinická onkologie, 2015-01, Vol.28 Suppl 4, p.4S48-4S55

2015

Volltextzugriff (PDF)

The Concept of Immunogenic Cell Death in Antitumor Immunity

Klinická onkologie, 2015-12, Vol.28 Suppl 4 (Suppl 4), p.4S48-4S55

2015

Volltextzugriff (PDF)

C18: Long-term immunotherapy using dendritic cells in patients with rising PSA after prostate cancer treatment with curative intention

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (6), p.e1218-e1218

2014

Volltextzugriff (PDF)

C156 Dendritic cell-based immunotherapy in patients with rising PSA after radical prostatectomy or salvage radiotherapy (phase I/II clinical trials)

European urology supplements : official journal of the European Association of Urology, 2013-10, Vol.12 (4), p.e1264, C156-e1264, C156

2013

Volltextzugriff (PDF)

Deep energy levels in N-type silicon introduced by palladium diffusion

1995 International Semiconductor Conference. CAS '95 Proceedings, 1995, p.163-166

1995

Volltextzugriff (PDF)

Photoluminescence quantum yield of PbS nanocrystals in colloidal suspensions

Journal of applied physics, 2015-04, Vol.117 (14)

2015

Volltextzugriff (PDF)

Identification of novel biomarker candidates for hypertrophic cardiomyopathy and other cardiovascular diseases leading to heart failure

Physiological research, 2016-01, Vol.65 (5), p.751-762

2016

Volltextzugriff (PDF)

TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

Clinical cancer research, 2019-08, Vol.25 (15), p.4820-4831

2019

Volltextzugriff (PDF)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

Journal for immunotherapy of cancer, 2018-12, Vol.6 (1), p.139-139, Article 139

2018

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents

Calreticulin and cancer

Detection of immunogenic cell death and its relevance for cancer therapy

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells

181P Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Effects of 5-azacytidine and trichostatin A on dendritic cell maturation

Trial watch: Immune checkpoint blockers for cancer therapy

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death

P03.24 Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients

FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer

Anthracyclins Induce Immunogenic Cell Death in Human Acute Lymphoblastic Leukemia Cell Lines

872 Long-term immunotherapy by dendritic-cells based vaccine in patients with PSA-recurrent prostate cancer

The Concept of Immunogenic Cell Death in Antitumor Immunity

The Concept of Immunogenic Cell Death in Antitumor Immunity

C18: Long-term immunotherapy using dendritic cells in patients with rising PSA after prostate cancer treatment with curative intention

C156 Dendritic cell-based immunotherapy in patients with rising PSA after radical prostatectomy or salvage radiotherapy (phase I/II clinical trials)

Deep energy levels in N-type silicon introduced by palladium diffusion

Photoluminescence quantum yield of PbS nanocrystals in colloidal suspensions

Identification of novel biomarker candidates for hypertrophic cardiomyopathy and other cardiovascular diseases leading to heart failure

TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

Suchergebnisse filtern